Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
EE Zijlstra - Frontiers in Cellular and Infection Microbiology, 2021 - frontiersin.org
Precision medicine and precision global health in visceral leishmaniasis (VL) have not yet
been described and could take into account how all known determinants improve …
been described and could take into account how all known determinants improve …
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the …
Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis which can occur
after successful treatment of visceral leishmaniasis (VL) and is a public health problem in VL …
after successful treatment of visceral leishmaniasis (VL) and is a public health problem in VL …
Demographic characteristics and prevalence of asymptomatic Leishmania donovani infection in migrant workers working in an endemic area in Northwest Ethiopia
M Yimer, Y Takele, E Yizengaw, E Nibret… - Frontiers in …, 2024 - frontiersin.org
Introduction Visceral leishmaniasis (VL), a neglected tropical disease that causes
substantial morbidity and mortality, is a serious health problem in Ethiopia. Infections are …
substantial morbidity and mortality, is a serious health problem in Ethiopia. Infections are …
Spurious laboratory results associated with immunoglobulin M gammopathy in a dog with multiple myeloma
SC Loane, DA Castillo, ALDM Peschard… - Journal of Veterinary …, 2022 - Wiley Online Library
An 11 year old female‐neutered Labrador presented for facial swelling. Clinicopathological
abnormalities included hyperglobulinemia, azotemia, hypercalcemia, nonregenerative …
abnormalities included hyperglobulinemia, azotemia, hypercalcemia, nonregenerative …
Post Kala-Azar dermal leishmaniasis following treatment with 10 mg/kg of single dose ambisome for visceral leishmaniasis in Bihar, India
In view of the significant role of Post kala-azar dermal Leishmaniasis (PKDL) patients in the
transmission/recurrence of visceral leishmaniasis (VL) outbreaks, control of PKDL is among …
transmission/recurrence of visceral leishmaniasis (VL) outbreaks, control of PKDL is among …
[图书][B] Leishmaniasis: Control and Elimination
OP Singh, R Kumar, C Petersen, S Sundar, E Le Rutte - 2022 - books.google.com
Leishmaniasis is a disease complex caused by Leishmania parasite with a digenetic life
cycle in the sandfly vector and the mammalian host. In India, visceral leishmaniasis (VL) …
cycle in the sandfly vector and the mammalian host. In India, visceral leishmaniasis (VL) …
Precision Medicine in Control of Visceral Leishmaniasis
EE Zijlstra - Leishmaniasis: Control and Elimination, 2022 - books.google.com
Precision medicine and precision global health in visceral leishmaniasis (VL) have not yet
been described and could take into account how all known determinants improve …
been described and could take into account how all known determinants improve …
[PDF][PDF] Challenges in the Treatment of Co-infection of Visceral Leishmaniasis and Hepatitis B/C Viruses
RK Topno, M Kumar, M Madhukar, VNR Das, R Kumar… - researchgate.net
There is a significant research gap in India due to incomplete investigation of
seroprevalence of coinfection with visceral leishmaniasis (VL), hepatitis B (HBV) and …
seroprevalence of coinfection with visceral leishmaniasis (VL), hepatitis B (HBV) and …